Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Moore

Showing results (101-110 of 231) with videos related to

Pageof 24
Sort By:
Communications Biology|August 16, 2020
Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotypeBenjamin S Simpson, Niedzica Camacho, Hayley J Luxton, et al.
European Radiology|July 30, 2021
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trialFrancesco Giganti, Eoin Dinneen, Veeru Kasivisvanathan, et al.
European Urology|December 30, 2020
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological ResearchJoseph M Norris, Benjamin S Simpson, Rhys Ball, et al.
Radiology|April 9, 2013
Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standardNimalan Arumainayagam, Hashim U Ahmed, Caroline M Moore, et al.
The British Journal of Radiology|July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
BMJ Open|November 30, 2017
Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomesSue M Evans, Jeremy L Millar, Caroline M Moore, et al.
Nature Reviews. Urology|July 19, 2019
Multiparametric MRI for prostate cancer diagnosis: current status and future directionsArmando Stabile, Francesco Giganti, Andrew B Rosenkrantz, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
Urologic Oncology|December 27, 2017
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic reviewNicholas A Faure Walker, Joseph M Norris, Taimur T Shah, et al.
European Urology Oncology|December 4, 2020
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the LiteratureRaisa S Abrams-Pompe, Stefano Fanti, Ivo G Schoots, et al.
Pageof 24

Showing results (101-110 of 231) with videos related to

Sort By:
Pageof 24
Communications Biology|August 16, 2020
Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotypeBenjamin S Simpson, Niedzica Camacho, Hayley J Luxton, et al.
European Radiology|July 30, 2021
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trialFrancesco Giganti, Eoin Dinneen, Veeru Kasivisvanathan, et al.
European Urology|December 30, 2020
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological ResearchJoseph M Norris, Benjamin S Simpson, Rhys Ball, et al.
Radiology|April 9, 2013
Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standardNimalan Arumainayagam, Hashim U Ahmed, Caroline M Moore, et al.
The British Journal of Radiology|July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
BMJ Open|November 30, 2017
Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomesSue M Evans, Jeremy L Millar, Caroline M Moore, et al.
Nature Reviews. Urology|July 19, 2019
Multiparametric MRI for prostate cancer diagnosis: current status and future directionsArmando Stabile, Francesco Giganti, Andrew B Rosenkrantz, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
Urologic Oncology|December 27, 2017
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic reviewNicholas A Faure Walker, Joseph M Norris, Taimur T Shah, et al.
European Urology Oncology|December 4, 2020
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the LiteratureRaisa S Abrams-Pompe, Stefano Fanti, Ivo G Schoots, et al.
Pageof 24